Nicotinamide Adenine Dinucleotide 1g & Tirzepatide's Successor : A UK Update
The recent interest in NAD+ supplementation, particularly at a significant dosage of 1g , continues to rise within the British medical community. At the same time , attention is firmly fixed on Retatrutide, a novel GLP-1 analogue being viewed by many as a potential successor to Tirzepatide. Right